ICBM 2027

Menu

Call for Abstracts Now Open

Submit your individual paper, poster, or rapid communication to ICBM 2027,
the 19th International Congress of Behavioral Medicine, Suntec Singapore, 28 – 31 July 2027.

Call for Abstracts

Looking to submit a symposia proposal instead?

If you are submitting a symposia proposal, please visit the Call for Symposia page.

Visit the Call for Symposia page →

The Transformative Power of Behavioral Medicine: Time to Act

Submit Your Research to ICBM 2027

The International Congress of Behavioral Medicine (ICBM 2027) invites researchers, clinicians, educators, practitioners, and policymakers to submit abstracts presenting original research, innovative methodologies, and advances in behavioral medicine.

Join an international community dedicated to advancing behavioral medicine through scientific excellence, interdisciplinary collaboration, and the translation of research into clinical practice, public health, and policy. Accepted abstracts will contribute to a dynamic scientific program showcasing the latest developments from across the field.

All submissions should present original, scientifically rigorous work with clearly defined objectives, appropriate methodology, completed results, and evidence-based conclusions. All abstracts will undergo peer review by the ICBM 2027 Scientific Program Committee.

We look forward to receiving your submission and welcoming you to ICBM 2027.

Download the Abstract Submission Guidelines Here

Important Dates

Abstract Submission DeadlineJanuary 8, 202723:59 GMT+8
Abstract Acceptance NotificationFebruary 12, 2027
Early Bird Registration OpensNovember 2, 2026
Early Bird Registration DeadlineMarch 19, 202723:59 GMT+8
Regular Registration OpensMarch 20, 2027
Congress DatesJuly 28–31, 2027

Abstract Submission is NOW OPEN

Abstract Submission Portal

Abstract Submission Guidelines

General Requirements

All submissions must be made electronically through the ICBM 2027 Abstract Submission Portal.

The submitting author serves as the primary contact for all correspondence and is responsible for:

  • Ensuring that all co-authors have reviewed and approved the submission prior to submission;
  • Communicating all correspondence and decisions from the Scientific Program Committee to co-authors; and
  • Ensuring that all submission information is accurate at the time of submission.

Authors may indicate a preferred Congress track and presentation format where applicable. The final allocation of abstracts to tracks, presentation formats, and sessions rests with the Scientific Program Committee.

Individual Papers

Maximum abstract length: 250 words, excluding:

  • Title
  • Author names
  • Institutional affiliations
  • Authors may indicate a preferred presentation format (Oral, Poster, or Rapid Presentation).

Required Abstract Structure 

Abstracts must be organized using the following headings: 

  • Background: Briefly describe the scientific, clinical, or public health context of the study and the rationale for conducting the research.
  • Purpose: Clearly state the study objective(s), research question(s), or hypothesis(es). 
  • Method: Summarize the study design, participants, procedures, measures, and analytical approach. 
  • Results: Present the principal findings with sufficient detail to support the conclusions. Whenever possible, include quantitative or qualitative results rather than statements indicating that results will be presented. 
  • Conclusions: State the implications, significance, or potential applications of the findings for research, clinical practice, public health, or policy. 

Formatting Guidelines 

  • Abstracts must be written in English.
  • Abstracts must be submitted using the required headings: Background, Purpose, Method, Results, and Conclusions.
  • Use clear, concise, and scientifically appropriate language.
  • Standard scientific abbreviations may be used without definition. Non-standard abbreviations must be defined at first use.
  • Use Arabic numerals for numbers, except when they appear at the beginning of a sentence.
  • Carefully proofread abstracts for grammar, spelling, and clarity prior to submission.
  • Once the abstract submission deadline has passed, submitted abstracts cannot be revised or replaced. 

Additional Guidance 

  • Abstracts should report completed analyses. Abstracts stating only that “results will be discussed” or “data will be presented” may not be accepted.
  • Commercial product names should be avoided; use generic names whenever possible.
  • References, tables, and figures are not permitted.
  • Abstracts should not contain identifying information within the body of the abstract if peer review is conducted anonymously. 

Life Course and Population Health 

  • Child, Adolescent, and Family Health
  • Aging and Healthy Longevity
  • Occupational Health and Well-being
  • Women’s, Men’s, and Reproductive Health 

Prevention, Behavior Change, and Intervention Science 

  • Behavior Change Theory and Interventions
  • Prevention Across the Care Continuum
  • Systems, Community, and Network Approaches
  • Intervention Effectiveness and Health Outcomes
  • Digital and Technology-Enabled Interventions 

Education, Communication, and Implementation 

  • Education, Training, and Professional Development
  • Health Education, Promotion, and Risk Communication
  • Shared Decision-Making and Patient Engagement
  • Health Systems, Policy, Dissemination, and Implementation Science 

Health Equity and Social Determinants 

  • Health Equity and Social Determinants of Health
  • Sexual, Gender, and Other Priority Populations
  • Community Engagement and Public Involvement
  • Patients, Public, Policy, and Practice 

Mechanisms of Health and Behavior 

  • Biological Mechanisms
  • Psychological and Behavioral Mechanisms
  • Social and Environmental Mechanisms
  • Theoretical Models and Frameworks
  • Placebo, Nocebo, and Treatment Context 

 Chronic Disease Prevention and Management 

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Prevention and Control
  • Chronic Pain and Persistent Conditions
  • Multimorbidity and Complex Care 

 Infectious Diseases and Global Health 

  • Infectious Diseases
  • HIV/AIDS
  • COVID-19 and Pandemic Preparedness
  • Tropical and Neglected Diseases
  • Vaccination and Prevention Behaviors 

 Emerging Topics 

  • Digital Health, AI, and Wearables
  • Climate Change and Planetary Health
  • Big Data and Data Science
  • Behavioral Economics
  • Co-production and Patient Engagement 

Important Policies

  • By submitting an abstract, authors confirm that the work is original, accurately represents the research conducted, and has not been previously published in a peer-reviewed journal. 
  • Authors may use artificial intelligence (AI) tools to assist with language editing or formatting. Authors remain fully responsible for the accuracy, originality, scientific integrity, and authorship of all submitted content. AI tools must not be listed as authors. 
  • Submission of an abstract grants ICBM permission to publish accepted abstracts in congress publications and proceedings. 
  • Each individual may be listed as the presenting author on a maximum of two (2) abstract submissions. There is no limit on co-authorship. 
  • Multiple submissions derived from the same dataset are permitted only where each abstract represents a distinct scientific contribution that could reasonably be developed into a separate peer-reviewed publication. Duplicate, overlapping, or fragmented submissions may be rejected. 
  • At least one presenting author for each accepted abstract must register for the congress and pay the applicable registration fee by the Early Bird Registration Deadline. 
  • Early Bird Registration Deadline: March 19, 2027 (23:59 GMT+8)  
  • Registration by the deadline is required for the abstract to:
    • Be included in the official congress publications; and 
    • Be scheduled for presentation. 
  • Each presenting author is responsible for their own congress registration and associated fees.
  • If a presenting author is unable to attend, they should arrange for an eligible co-author to present the work in person, subject to congress policies.
  • Failure to register by the required deadline may result in removal of the abstract from the scientific program and congress publications. 

All submissions will undergo peer review and will be evaluated according to the following criteria: 

  • Scientific merit and innovation
  • Methodological quality and rigor
  • Significance and potential impact
  • Relevance to behavioral medicine and congress theme
  • Clarity of presentation 

The Scientific Program Committee reserves the right to determine the final presentation format, session allocation, and Congress track for all accepted submissions. All decisions of the Committee are final.

Individual Scientific Abstracts 

Abstracts submitted as individual scientific presentations should be based on empirical research and report completed findings. Abstracts containing statements such as “Results will be presented” or “Results will be discussed” are unlikely to be accepted. 

Definition of Empirical Research  

Empirical research includes, but is not limited to: 

  • Primary quantitative research (e.g., observational studies, clinical trials, experimental studies);
  • Primary qualitative research (e.g., interviews, focus groups, ethnographic studies);
  • Mixed-methods research; and
  • Secondary research that applies recognized and systematic methodologies, including systematic reviews, meta-analyses, meta-syntheses, scoping reviews, and other evidence synthesis approaches. 

Empirical submissions should employ appropriate and accepted methods for data collection, analysis, and interpretation. 

Traditional literature reviews that do not use a recognized evidence synthesis methodology will not be considered empirical research. Such work may, however, be appropriate for courses, panels, or symposia where relevant. 

The Scientific Program Committee is committed to maintaining the highest standards of scientific integrity and ethical conduct. 

By submitting an abstract, authors confirm that: 

  • The work accurately represents the research conducted;
  • All listed authors have made appropriate scholarly contributions and have approved the submission;
  • All applicable institutional ethics approvals and participant consent requirements have been met, where relevant; and
  • Any financial or other conflicts of interest have been disclosed in accordance with congress requirements. 

Scientific misconduct includes, but is not limited to: 

  • Plagiarism, including presenting another person’s ideas, data, text, or results as one’s own;
  • Fabrication, falsification, or manipulation of data or research findings;
  • Intentional misrepresentation of methods or results;
  • Duplicate or redundant publication or submission; and
  • Other practices that compromise the integrity of the scientific record. 

Where concerns regarding research or publication misconduct arise, the Scientific Program Committee reserves the right to investigate the matter. Authors will be given an opportunity to respond to any concerns in a timely manner. Confirmed misconduct, or failure to respond to requests for clarification, may result in one or more of the following actions: 

  • Rejection of the abstract;
  • Removal of the presentation from the congress program;
  • Retraction of the published abstract; and/or
  • Restriction of future abstract submissions to ICBM. 

Authors who need to withdraw an abstract should notify the Scientific Program Committee in writing as early as possible. 

Failure to present an accepted abstract without prior notification may affect eligibility for future ICBM abstract submissions. 

Exceptions may be considered in circumstances beyond the author’s control, including: 

  • Significant travel disruption (e.g., severe weather);
  • Work-related emergencies; or
  • Personal illness or family medical emergencies. 

Registration fees are subject to the congress cancellation and refund policy. 

Call for Nominations for Early Career Awards for ICBM 2027 in Singapore

The Governing Council of ISBM will present up to ten Early Career Awards, each in the value of USD 500, to encourage a further career in behavioral medicine. The awards will be distributed at a congress ceremony, where all awardees are expected to be present. Some additional ISBM funds are available for award winners from countries with limited resources, to partially cover conference-related costs.  

Recipients will have distinguished themselves scientifically or in their clinical practice career.

Submission Deadline: January 8, 2027, 23:59 (GMT+8)  
Application Notification: by end of May 2027  

The Early Career Award application deadline is the same as the abstract submission deadline. Late submissions will not be accepted. 

Should you have any questions, please contact icbm2027-programme@icsevents.com. 

Selection of the Early Career Award is based on total career achievement and review of a submitted and accepted abstract. To qualify for this award, the applicant has to meet the eligibility criteria listed below: 

  • Should be no more than seven (7) years out from their highest degree, and/or have held a faculty or professional position for no more than seven (7) years. 
  • Must submit an abstract of empirical work. 
  • Must be the first or only author of the accepted abstract.
  • Attendance and presentation at the congress is required. 

Priority may be given to applications from countries with limited resources, and/or representatives from different geographical regions.  

Priority may be given to applications from countries with limited resources, and/or representatives from different geographical regions.

In addition to submitting an abstract for ICBM2027, applicants are asked to self-nominate for the early career award during abstract submission and upload the following documents: 

  • A short curriculum vitae (max 4 pages)
  • A personal statement (max 1 page) providing an overview of your research achievements to date with full contact details (name, postal address, phone, fax, email) 
  • Submitted abstract via the abstract submission portal. 

You may apply for the Early Career Award during or after your abstract submission/registration, provided the submission deadline has not passed. 

Apply During Abstract Submission / Registration 

Step 1: Access the Abstract Submission Portal & Create Your Account 

  • Click the ICBM 2027 Abstract Submission Portal to get started.
  • First-time users: Click “Create New Account”, fill in your email address and create a password to confirm and proceed. 
  • Click on the Contact Info tab to begin. 

Step 2: Complete Your Contact Information 

  • Click on the Contact Info tab.
  • First-time users: Click “Create Contact” and fill in your personal details (name, organisation, email address, and headshot).

Step 3: Indicate Your Early Career Award Application 

  • At the bottom of the Contact Information page, you will find the following checkbox: “I am submitting an application for the Early Career Award”
  • Tick this checkbox to proceed to the Early Career Award Application submission page. 

 Step 4: Upload Your Supporting Documents 

  • On the Early Career Award Application page, upload the following:
    • Curriculum Vitae (CV) (max 4 pages) 
    • Personal Statement (max 1 page) 
  • Once uploaded, click Submit to complete your award application. 

Step 5: Submit Your Abstract 

  • After completing the Early Career Award application, proceed to the Abstract Submission tab.
  • Submit your abstract as per the standard submission process. 

Apply After Abstract Submission / Registration 

If you have already submitted your abstract/registered and wish to apply for the Early Career Award separately: 

Step 1: Log In to the Abstract Submission Portal 

Step 2: Navigate to Your Contact Information 

  • Click on the Contact Info tab.
  • Returning users: Click “Edit Contact Details” to update your information. 

Step 3: Indicate Your Early Career Award Application 

  • At the bottom of the Contact Information page, you will find the following checkbox:  “I am submitting an application for the Early Career Award”
  • Tick this checkbox to proceed to the Early Career Award Application submission page. 

 Step 4: Upload Your Supporting Documents 

  • On the Early Career Award Application page, upload the following:
    • Curriculum Vitae (CV) (max 4 pages)
    • Personal Statement (max 1 page) 

Once uploaded, click Submit to complete your award application. 
Your previously submitted abstract will be automatically associated with your Early Career Award application.

The applications will be judged by a panel consisting of the Chair of the ISBM Education and Training Committee, members of the Education and Training Committee, and senior ISBM members. Awardees will be selected based on the following criteria: 

  • Quality and rating of the submitted abstract.
  • Curriculum vitae and total career achievement.
  • Balanced representation of geographical region, gender, and scientific background (basic mechanisms, clinical research, and public health research).  
Scroll to Top